Skip to main content
Download PDF

The impact of blood lactic acid levels on retinopathy of prematurity morbidity

BMC Pediatrics volume 24, Article number: 152 (2024) Cite this article

Abstract

Background

Retinopathy of prematurity (ROP) is a common disease in premature infants. In recent years, most researchers have used lactic acid as poor prognosis marker in premature infants. This study aims to explore investigate the impact of blood lactic acid levels on ROP.

Methods

A retrospective case-control study was conducted, and infants with severe ROP born with birth weight (BW) ≤ 1500 g and gestational age (GA) ≤ 32 weeks were enrolled from November 2016 to November 2021. Infants without any stage ROP were included as controls and were matched with ROP infants (1:2) by GA and BW. All selected preterm infants were tested for heel terminal trace blood gas analysis within two weeks of life. Changes in blood lactic acid levels in the two groups were compared and analyzed by using multivariate logistic regression analysis. Sensitivity and specificity were analyzed by receiver operating characteristic (ROC) curve.

Results

There were 79 infants in ROP group, and 158 infants in control group. The levels of blood lactic acid were significantly higher in the ROP group on days 1, 3, 5, and 7 compared with control group (all p < 0.05). The blood lactic acid levels on day 5 was an independent risk factor for ROP (p = 0.017). The area under the curve (AUC), sensitivity and specificity were highest on day 5 (AUC 0.716, sensitivity 77.2% and specificity 62.0%, respectively, p < 0.001), and higher on days 1, 3, and 7.

Conclusion

A high blood lactic acid level in the first seven days of life may be associated with increases ROP occurrence in very preterm infants, and suggest blood lactic acid level may impact the occurrence of ROP.

Brief summary statement

Retinopathy of prematurity is a retinal vascular proliferative disease that endangers visual development in very preterm infants. This study investigated the impact of blood lactic acid levels on ROP by conducting a retrospective case-control study, and suggested relationship between lactic acid level and the occurrence of ROP.

Peer Review reports

Introduction

Retinopathy of prematurity (ROP) is a retinal vascular proliferative disease that endangers visual and retinal development in very preterm infants [1]. ROP is the insufficiency of retinal blood vessels due to preterm birth, abnormal neonatal vascular proliferation, and fibroplasia in the retina without a vascular area [2]. It is a significant cause of childhood visual impairment and blindness worldwide [3]. A physiological hypoxic state was provided by normal intrauterine environment, which drives retinal angiogenesis and maturation of the retinal nerve sensory.[4] But abnormal intrauterine environment, such as chronic chorioamnionitis is associated with early-onset neonatal sepsis, metabolic acidosis and retinopathy of prematurity [5]. Metabolic acidosis is early risk factors for retinopathy of prematurity in preterm infants. The development of metabolic acidosis during chorioamnionitis is generally thought to be an increase in lactic acid due to proton release and sodium lactate formation [6, 7]. Several researchers have used blood lactic acid levels as a biomarker of poor prognosis in infants with very low or extremely low BW [8]. A previous study reported that the nucleated red blood cell count and serum lactic acid concentration are valuable biomarkers for predicting important outcomes in infants with very low birth weight [9].

Lactic acid is an intermediate product of in vivo glucose metabolism mainly produced by red blood cells, striated muscle, and brain tissues. Lactic acid is primarily produced under anaerobic conditions; tissue hypoxia can elevate lactic acid levels in the body. Hypoxia stimulates retinal vascular endothelial growth factor (VEGF) synthesis and neovascularization. High lactic acid levels can independently induce retinal VEGF generation depending on the lactic acid concentration [10]. A hypoxic environment increases retinal lactic acid levels seven-fold [11]. The lactic acid-induced VEGF expression mechanism alludes to its role in retinal neovascularization, suggesting that mechanisms other than hypoxia can stimulate retinal VEGF production, and that the combination of hyperlactic acid concentrations and hypoxia can further induce VEGF production [10].

The mechanism of lactic acid-induced VEGF expression is associated with the downregulation of adenosine diphosphate ribose. Adenosine diphosphate-ribosylation is a common post-translational protein modification. The high concentration of lactic acid forces lactic acid dehydrogenase to catalyze the conversion of nicotinamide adenine dinucleotide to reduced nicotinamide adenine dinucleotide. This effect of lactic acid on the conversion has resulted in speculations on its effect on the transcriptional rate and activity of VEGF [10]. Therefore, lactic acid values can provide information on cellular metabolic levels and reflect the actual oxygenation state of cells. Blood lactic acid levels have been shown to be easily detectable in the NICU through blood gas analysis. Arterial and venous lactic acid values are similar; therefore, blood lactic acid values can also be analyzed using heel tip trace blood gas analysis. The amount of data available on the predictive value of lactic acid in the association of lactic acid with morbidity and mortality in preterm infants is increasing [12]. Higher blood lactic acid levels were found during the blood gas analysis of preterm infants with pre-threshold or threshold disease ROP in clinical work. Therefore, it was speculated that blood lactic acid levels might influence ROP occurrence. This study aimed to explore the effect of blood lactic acid levels on ROP and its occurrence.

Materials and methods

A retrospective case-control study was conducted between November 2016 and November 2021 at the Children’s Hospital affiliated to Zhengzhou University. The study has been approved by the Ethics Committee of the Children’s Hospital Affiliated to Zhengzhou University and was conducted in accordance with the provisions of the Declaration of Helsinki.

Patient population

Neonates born with BW ≤ 1500 g and GA ≤ 32 weeks were enrolled in the study. Infants without any staged ROP were included as controls and matched with infants with ROP (1:2) by GA and BW. Infants with genetic metabolic diseases, congenital abnormalities, congenital heart disease, or infections were excluded.

Data collection

Primary data were collected on the enrolled infants, including sex; GA; BW; blood gas analysis (including blood lactic acid); as well as treatment and related complications, including duration of mechanical ventilation; intracranial hemorrhage; necrotizing enterocolitis; sepsis; bronchopulmonary dysplasia; and blood transfusions.

Screening and classification of ROP

ROP screening in the enrolled infants was performed by two experienced ophthalmologists using the Retcam III Wide Cape Digital Retina Imaging System (Massie, USA). ROP screening was performed and diagnosed as stages 1–5 according to the International Classification of ROP, [13] defined as follows: type 1 ROP, any stage ROP with “plus” disease, stage 3 ROP without plus disease in zone I, or stage 2 or 3 ROP with plus disease in zone II; and type 2 ROP, stage 1 or 2 ROP in zone I without plus disease, or stage 3 ROP in zone II without plus disease. Severe ROP was defined as more than stage 3 ROP and requirement of treatment.

Blood lactic acid test

All selected preterm infants were tested for heel terminal trace blood (35 µl) gas analysis within two week of life, the frequency of blood gas analysis according to infant’s condition. For infants on ventilators, daily blood gas analysis, including pH, PCO2, PO2, and blood lactic acid, was tested. The test was performed using a fully automated blood gas analyzer (ABL90 FIEX, Denmark), and the blood gas analysis parameter including pH, PCO2, PO2, and lactic acid level, and so on. We collected lactic acid from blood gas analysis data of days 1, 3, 5, 7, and 14.

Statistical analysis

SPSS 22.0 was used to analyze the data. Quantitative data were expressed as mean ± standard deviation. Entry data and outcome differences were compared between two groups using t- test for normal distribution, and using non-parametric tests (Mann Whitney U test) for non-normal distribution. lactic acid in different times used ANOVA test. Count data were expressed as rates (%) and compared using chi-square tests. Potential confounders were adjusted by performing multiple logistic regression analyses. The sensitivity and specificity of blood lactic acid levels in ROP were analyzed by using ROC curve. Statistical significance was set at p < 0.05.

Results

Characteristics of baseline

1,798 preterm infants with GA ≤ 32 weeks and BW ≤ 1500 g were assessed for eligibility during the study period. Of these, 88 premature infants with severe retinopathy of prematurity excluded 9 infants because of incomplete data and meeting exclusion criteria, respectively. Finally, 79 infants with ROP were recruited, and 158 sex-matched infants with similar GA and BW without ROP were included in the control group (Fig. 1). There were 49 males and 30 females in the ROP group (GA, 24–32 weeks; BW, 500–1500 g). The control group consisted of 104 males and 54 females (GA, 24–32 weeks; BW, 510–1500 g). Baseline characteristics were similar in both groups beside of maternal chorioamnionitis and Apgar Scores at 5 min. There were higher rates of chorioamnionitis and lower Apgar Scores at 5 min in the ROP group compared to control group (p = 0.033 and p = 0.037, respectively). (Table 1).

Fig. 1
figure 1

Flow chart describing the enrollment of the severe ROP cases and controls

Full size image
Table 1 Baseline characteristics of all the infants enrolled in study
Full size table

A comparison of clinical characteristics of the infants in the two groups revealed that days of mechanical ventilation and total parenteral nutrition were longer, and the number of transfusions was higher in the ROP group than in the control group (p = 0.004, p = 0.003, and p = 0.008, respectively). The incidence of sepsis, bronchopulmonary dysplasia, intracranial hemorrhage, and necrotizing enterocolitis was similar between the two groups. (Table 2).

Table 2 Clinical characteristics of infants in two groups
Full size table

Outcomes of blood lactic acid levels

OPLS-DA score plot revealed a clear and separate clustering between premature infants with and without ROP (Fig. 2). This collectively suggest that this Model fits the data very well and has good predictive ability. There was a significant difference in the blood lactic acid levels between the two groups on days 1, 3, 5, and 7. In addition, blood lactic acid levels were higher in the ROP group than in the control group (all p < 0.05) (Table 3).

Fig. 2
figure 2

OPLS-DA score scatter plot offrst two principal components (ROP and control groups). Clear separate clustering can be observed between ROP and non- control groups

Full size image
Table 3 Comparison of blood lactic acid between the two groups
Full size table

Multivariate logistic regression analysis adjusted for potential confounding factors of ROP revealed that higher blood lactic acid levels last for 5 days increased the risk of ROP occurrence in the ROP group as compared to the control group. In addition, the model was adjusted for birth weight, maternal chorioamnionitis, Apgar scores at 5 min, the duration of mechanical ventilation and blood transfusions. The results showed that changes in blood lactic acid levels in the first seven days of life were associated with the occurrence of ROP (p < 0.05)(Table 4).

Table 4 multiple logistic regression analysis of the predict factors of blood lactic acid levels for severe ROP
Full size table

ROC curve analysis was used to analyze the sensitivity and specificity of blood lactic acid levels in the ROP group on varying postnatal days. The results showed that the area under the curve (AUC), sensitivity, and specificity peaked on day 7 (0.716, 77.2, and 62.0%, respectively; p < 0.001) and were lower on day 14. However, the difference was not statistically significant. The results are summarized in Table 5.

Table 5 Prediction of ROP by blood lactic acid levels in different postnatal days
Full size table

Discussion

Lactic acid has been used in many clinical studies as a predictor of patient morbidity and mortality. Clinical studies have reported a correlation between blood lactic acid levels and morbidity or mortality [14]. However, there is no consensus on the threshold of hyperlactic acidmia that should be used to predict complications during lactic acid elevation [15]. Lactic acid is produced in the hypoxic conditions and can be produced and metabolized by all tissues in the body. Information about metabolic capacity at the cellular level can be provided by lactic acid values, and true perfusion and oxygenation status were reflected [16]. Lactic acid is known to have multiple roles in cell homeostasis as a metabolic fuel and buffer, which acts as a signaling molecule called “Lactormone” and mediates this signaling through the hydroxy-carboxylic acid recptor 1 [17]. Hydroxy-carboxylic acid receptor 1 is a G-protein-coupled receptor activated by L-lactic acid and the exogenous agonist 3, 5-dihydroxybenzoic acid, also known as GPR81 [18]. It is expressed in a variety of organs including brain, retina, kidney, adipose tissue, liver rand skeletal muscle [19]. GPR81 has been found to mediate the effects of L-lactic acid in a variety of processes, including angiogenesis, wound healing, inhibition of inflammation, and neuroprotection [20]. This study found no significant difference in blood lactic acid levels between the ROP and control groups on day 14 of life. However, the infants in the ROP group had significantly higher postnatal blood lactic acid levels on days 1, 3, 5, and 7 of life than the controls (p < 0.05). Multivariate logistic regression analysis revealed that an elevated blood lactic acid level was a risk factor for the development of ROP, suggesting that increased mean blood lactic acid levels may impact the occurrence of ROP. However, no differences in lactic acid levels with respect to sex were found in this study. High lactic acid levels during the first few days of life reflect circulatory impairment and poor perfusion. Peripheral retinal hypoxia may contribute to worsening ROP [21]. Some reports indicated that neonatal asphyxia and acidosis in early of life were strongly associated with reduced IGF-1 levels [22]. With this knowledge, we can assume that the results of our study were the result of peripheral retinal hypoxia in conjunction with IGF-1 inhibition.

Retinopathy of prematurity is a vascular dysproliferative retinopathy that occurs in preterm infants. ROP is the major cause of visual loss and blindness in children, which is a multifactorial disease. The pathogenesis of ROP is divided into two stages: stage I, retinal vascular obstruction or blocked development; and stage II, neovascularization, followed by retinal hypoxia. In the normal intrauterine environment, the angiogenic stimulus is provided by VEGF beginning around 25 to 26 weeks gestation, with complete retinal vascularization by 40 weeks gestation [23].

Hyperoxic environment plays a role in the pathogenesis of ROP. However, For infants with the maintains of SaO2 was between 92–95% [24], Oxygen supplementation had no significant effects on the retina. However, a greater incidence of adverse pulmonary effects, including pneumonia and increased severity of chronic lung disease, was observed in the supplemented group. Thus, while it seems prudent to avoid chronic or episodic hypoxia in infants at risk for developing threshold ROP, the benefit of oxygen supplementation in excess of the minimum required to maintain tissue oxygenation and pulmonary homeostasis remains to be determined [25].

VEGF and its receptors play important roles in regulating neoangiogenesis. The rate of glycolysis is very high in the normal retina. Winkler et al. [26] reported that approximately 90% of glucose transfer in isolated rat retinas produced lactic acid under aerobic conditions and that the lactic acid concentration in the retina is higher than that in other tissues. The steady-state concentrations of glucose and lactic acid in the aqueous humor and vitreous fluid of the eye are reported to be 5 and 10 mM, respectively. [26] Under hypoxic conditions, glycolysis increases, and retinal circulation cannot remove excess lactic acid, resulting in a more significant accumulation of lactic acid in the retina.

Lactic acid, which plays an important role in retinal metabolism, is consumed mainly by photoreceptors supplied as a major fuel and coupled to the glutamate-glutamine cycle to power the interactions between photoreceptors and glia. Previous studies on retinal microvessels have shown that lactic acid can act as a vasoconstrictor when there is a sufficient energy supply, but as a vasodilator under hypoxic conditions intravenous administration of lactic acid can increase blood flow to the retina in rats. Injection of lactic acid into the vitreous of porcine eyes resulted in the dilation of retinal blood vessels > 70 μm in diameter [27]. In this study, the blood lactic acid levels were higher and oxygen saturation was lower in the first seven days of life in the ROP group. This result was similar to that of a previous study. Lactic acid is produced under anaerobic conditions and can be metabolized by all body tissues. Lactic acid values can provide information on metabolic capacity at the cellular level and reflect the true perfusion and oxygenation status [28]. A previous study reported that a single lactic acid value > 5.6 mmol/l had a sensitivity of 100% and specificity of 85% for identifying adverse outcomes. Persistently elevated or worsening lactic acid levels are associated with adverse outcomes [12]. In neonates admitted to a level-III NICU, arterial lactic acid levels within 3 h of birth were significantly higher in preterm neonates with poor neurodevelopmental outcome or death [29]. Serum lactic acid concentrations on day 5 of life are associated with retinopathy of prematurity, bronchopulmonary dysplasia, and intraventricular hemorrhage. Therefore, serum lactic acid concentration is a valuable biomarker for predicting important outcome parameters in infants born with very low BW [9].

Limitation in our study must be mentioned. At first, a retrospective study has many intrinsic limitations besides the measurements. Second, for infants with invasive and non-invasive ventilation or with high flow oxygen, we did twice blood gas to measure PaCO2, PaO2 (maintain 70–90 mmHg), and SaO2, and measure SpO2 using Philips Medizin systeme monitor. But for infants with nasal oxygen, we only measure SpO2 using Philips Medizin systeme monitor, and PaO2 was missed. Third, We only compared the outcomes for survives with severe ROP and not for the composite outcome of severe ROP or death in NICU, there may result in a selection bias.

the composite outcome of severe ROP or death in NICU. Only infants who survived to discharge may result in a selection bias.

Lactic acid plays an essential role in retinal metabolism. The results of this study suggest a correlation between blood lactic acid levels and the occurrence of severe ROP; a high blood lactic acid level in the first seven days of life may be associated with increases ROP occurrence in very preterm infants. Lactic acid may play a role in the development of ROP and is not just a biomarker. A further investigation of the relationship between blood lactic acid levels and ROP at the molecular biology level may be required.

Data availability

No datasets were generated or analysed during the current study.

Abbreviations

ROP:

retinopathy of prematurity

RR:

risk rate

CI:

confidence interval

SD:

standard deviation

ROC:

receiver operating characteristic curve

VEGF:

vascular endothelial growth factor

PMA:

postmenstrual age

VLBW:

very low birth weight infants

NEC:

necrotizing enterocolitis

BPD:

bronchopulmonary dysplasia

ETROP:

Early Treatment for Retinopathy of Prematurity

References

  1. Sabri K, Ells AL, Lee EY, Dutta S, Vinekar A. Retinopathy of Prematurity: A Global Perspective and recent developments. Pediatrics 2022, 150(3).

  2. Fevereiro-Martins M, Marques-Neves C, Guimarães H, Bicho M. Retinopathy of prematurity: a review of pathophysiology and signaling pathways. Surv Ophthalmol. 2023;68(2):175–210.

    Article  PubMed  Google Scholar 

  3. Hartnett ME. Retinopathy of Prematurity: evolving treatment with anti-vascular endothelial growth factor. Am J Ophthalmol. 2020;218:208–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Paisley CE, Kay JN. Seeing stars: development and function of retinal astrocytes. Dev Biol. 2021;478:144–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Jain VG, Willis KA, Jobe A, Ambalavanan N. Chorioamnionitis and neonatal outcomes. Pediatr Res. 2022;91(2):289–96.

    Article  PubMed  Google Scholar 

  6. Fowler JR, Simon LV. Chorioamnionitis. In: StatPearls edn. Treasure Island (FL) ineligible companies. Disclosure: Leslie Simon declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.

  7. Torrens SL, Robergs RA, Curry SC, Nalos M. The Computational Acid-Base Chemistry of hepatic ketoacidosis. Metabolites 2023, 13(7).

  8. Escourrou G, Renesme L, Zana E, Rideau A, Marcoux MO, Lopez E, Gascoin G, Kuhn P, Tourneux P, Guellec I, et al. How to assess hemodynamic status in very preterm newborns in the first week of life? J Perinatology: Official J Calif Perinat Association. 2017;37(9):987–93.

    Article  CAS  Google Scholar 

  9. Poryo M, Wissing A, Zemlin M, Aygün A, Ebrahimi-Fakhari D, Geisel J, Schöpe J, Wagenpfeil S, Sauer H, Meyer S. Nucleated red blood cells and serum lactate values on days 2 and 5 are associated with mortality and morbidity in VLBW infants. Wien Med Wochenschr. 2019;169(3–4):87–92.

    Article  PubMed  Google Scholar 

  10. Zhu D, Zhou J, Xu X. Influence of lactic acid on differential expression of vascular endothelial growth factor and pigment epithelium-derived factor in explants of rat retina. Curr Eye Res. 2012;37(11):1025–9.

    Article  CAS  PubMed  Google Scholar 

  11. Nyengaard JR, Ido Y, Kilo C, Williamson JR. Interactions between hyperglycemia and hypoxia: implications for diabetic retinopathy. Diabetes. 2004;53(11):2931–8.

    Article  CAS  PubMed  Google Scholar 

  12. Nadeem M, Clarke A, Dempsey EM. Day 1 serum lactate values in preterm infants less than 32 weeks gestation. Eur J Pediatrics. 2010;169(6):667–70.

    Article  CAS  Google Scholar 

  13. Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A, Binenbaum G, Blair M, Peter Campbell J, Capone A Jr et al. International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology 2021, 128(10):e51-e68.

  14. Fuller BM, Dellinger RP. Lactate as a hemodynamic marker in the critically ill. Curr Opin Crit Care. 2012;18(3):267–72.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kruse O, Grunnet N, Barfod C. Blood lactate as a predictor for in-hospital mortality in patients admitted acutely to hospital: a systematic review. Scand J Trauma Resusc Emerg Med. 2011;19(74):1757–7241.

    Google Scholar 

  16. Allen M. Lactate and acid base as a hemodynamic monitor and markers of cellular perfusion. Pediatr Crit care Medicine: J Soc Crit Care Med World Federation Pediatr Intensive Crit Care Soc. 2011;12(4 Suppl):S43–49.

    Article  Google Scholar 

  17. Ferguson BS, Rogatzki MJ, Goodwin ML, Kane DA, Rightmire Z, Gladden LB. Lactate metabolism: historical context, prior misinterpretations, and current understanding. Eur J Appl Physiol. 2018;118(4):691–728.

    Article  CAS  PubMed  Google Scholar 

  18. Liu C, Kuei C, Zhu J, Yu J, Zhang L, Shih A, Mirzadegan T, Shelton J, Sutton S, Connelly MA, et al. 3,5-Dihydroxybenzoic acid, a specific agonist for hydroxycarboxylic acid 1, inhibits lipolysis in adipocytes. J Pharmacol Exp Ther. 2012;341(3):794–801.

    Article  CAS  PubMed  Google Scholar 

  19. Madaan A, Chaudhari P, Nadeau-Vallée M, Hamel D, Zhu T, Mitchell G, Samuels M, Pundir S, Dabouz R, Howe Cheng CW, et al. Müller Cell-localized G-Protein-coupled receptor 81 (hydroxycarboxylic acid receptor 1) regulates inner retinal vasculature via Norrin/Wnt pathways. Am J Pathol. 2019;189(9):1878–96.

    Article  CAS  PubMed  Google Scholar 

  20. Porporato PE, Payen VL, De Saedeleer CJ, Préat V, Thissen JP, Feron O, Sonveaux P. Lactate stimulates angiogenesis and accelerates the healing of superficial and ischemic wounds in mice. Angiogenesis. 2012;15(4):581–92.

    Article  CAS  PubMed  Google Scholar 

  21. Barnett JM, Yanni SE, Penn JS. The development of the rat model of retinopathy of prematurity. Doc Ophthalmol. 2010;120(1):3–12.

    Article  PubMed  Google Scholar 

  22. Dinleyici EC, Tekin N, Colak O, Aksit MA. Cord blood IGF-1 and IGFBP-3 levels in asphyxiated term newborns. Neuro Endocrinol Lett. 2006;27(6):745–7.

    CAS  PubMed  Google Scholar 

  23. Hughes S, Yang H, Chan-Ling T. Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Investig Ophthalmol Vis Sci. 2000;41(5):1217–28.

    CAS  Google Scholar 

  24. Lakshminrusimha S, Manja V, Mathew B, Suresh GK. Oxygen targeting in preterm infants: a physiological interpretation. J Perinatology: Official J Calif Perinat Association. 2015;35(1):8–15.

    Article  CAS  Google Scholar 

  25. Hay WW Jr., Bell EF. Oxygen therapy, oxygen toxicity, and the STOP-ROP trial. Pediatrics. 2000;105(2):424–5.

    Article  PubMed  Google Scholar 

  26. Winkler BS, Starnes CA, Sauer MW, Firouzgan Z, Chen SC. Cultured retinal neuronal cells and Müller cells both show net production of lactate. Neurochem Int. 2004;45(2–3):311–20.

    Article  CAS  PubMed  Google Scholar 

  27. Mendrinos E, Petropoulos IK, Mangioris G, Tsilimbaris MK, Papadopoulou DN, Geka A, Pournaras CJ. Vasomotor effect of intravitreal juxta-arteriolar injection of L-lactate on the retinal arterioles after acute branch retinal vein occlusion in minipigs. Investig Ophthalmol Vis Sci. 2011;52(6):3215–20.

    Article  CAS  Google Scholar 

  28. Allen M. Lactate and acid base as a hemodynamic monitor and markers of cellular perfusion. Pediatr Crit Care Med 2011, 12(4 Suppl).

  29. Groenendaal F, Lindemans C, Uiterwaal CS, de Vries LS. Early arterial lactate and prediction of outcome in preterm neonates admitted to a neonatal intensive care unit. Biol Neonate. 2003;83(3):171–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by the Department of Science and Technology of Henan Province of China (162102310001), and the Department of Science and Technology of Zhengzhou of China (20150153). We thank the parents for allowing their extremely preterm infants to take part in this study, and paediatric ophthalmologists, and the Research Centers of the Children’s Hospital affiliated to Zhengzhou University and Zhecheng People’s Hospital for their assistance.

Funding

Funding was provided by the Department of henan Provincial Health Commission (YXKC2021022) .

Author information

Authors and Affiliations

  1. Department of Pediatrics, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    Congcong Zhao

  2. Department of Neonatology, Children’s Hospital affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, 33 Longhuwaihuan Road, Zhengzhou, 450018, China

    Zhihong Sun & Huiqing Sun

  3. Department of Neonatology, Zhecheng People’s Hospital, Henan, China

    Hongming Chen & Kaili Li

Authors
  1. Congcong Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhihong Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hongming Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kaili Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Huiqing Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CZ and ZS did the equal works. Concept and study design: HS. Data acquisition and analysis: CZ, ZS, HC, KL. Drafting the manuscript and the figures: CZ, ZS, HS. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Corresponding author

Correspondence to Huiqing Sun.

Ethics declarations

Ethics approval and consent to participate

All methods in this study were carried out in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from a parent and/or legal guardian. The Life Science Ethics Committee of Children’s Hospital affiliated to Zhengzhou University approved the study (IRB number 20180416).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Financial disclosure

The authors have no financial relationships relevant to this article to disclose.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, C., Sun, Z., Chen, H. et al. The impact of blood lactic acid levels on retinopathy of prematurity morbidity. BMC Pediatr 24, 152 (2024). https://doi.org/10.1186/s12887-024-04571-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12887-024-04571-y

Keywords

BMC Pediatrics

ISSN: 1471-2431

Contact us